MAIA Biotechnology, Inc. (New York Stock Exchange Arca:MAIA)
| Market Cap | 69.01M-37.3% |
| Revenue (ttm) | 0 |
| Net Income | -26.85M-66.0% |
| EPS | -0.63-7.5% |
| Shares Out | 60.80M |
| PE Ratio | n/a |
| Forward PE | 1.02 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 191,003 |
| Open | 1.15 |
| Previous Close | 1.18 |
| Day's Range | 1.14 - 1.16 |
| 52-Week Range | 0.87 - 3.19 |
| Beta | 0.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
MAIA Biotechnology, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 2 insiders in the last 90 days.
About MAIA
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MAIA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in MAIA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MAIA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MAIA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MAIA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MAIA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MAIA
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $2.20M |
| VXFVanguard Extended Market ETF | $875.23K |
| IWCiShares Micro-Cap ETF | $199.95K |
| BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | $90.00K |
Estimated from each fund’s disclosed top holdings × AUM
MAIA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MAIA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score